AI Healthcare
B Aatral Biosciences is developing cutting edge technology for Diseases prediction, Diagnosis and Drug Discovery platform
The emergence of artificial intelligence (AI) as a tool for better health care offers unprecedented opportunities to improve patient and clinical team outcomes, reduce costs, and impact population health. AI has piqued the attention of researchers, physicians, technology and program developers, and consumers in various fields in terms of its potential for transformational advances in treating human diseases and public health. As AI-supported technologies learn and diagnose from a large volume of medical research and patients’ treatment records, they play a significant role in supplementing doctors’ decision-making process for diagnoses and treatment.
AI-Based healthcare could revolutionize disease diagnosis by early detection, automation in analysis and consolidated comparison by mining large number of varied datasets from data base for better prediction of disease progression and decision making in treatment. AI-based diagnostic algorithms are applied in the detection of various diseases and disorders. It was also reported that AI technology could diagnose disease more accurately, swiftly and efficiently because it is analysed based on knowledge gained from a large body of knowledge and data. By doing this AI could create a big impact on personalised medicine by rapid diagnosis and therapeutic intervention, allowing for more precisely tailored early treatments. AI algorithms can now achieve notable success in predicting risk in cancers and various disease (includes cardiovascular and neurodegenerative) from available multidimensional clinical and biological data.
B Aatral Biosciences thrust areas where AI/Ml could be deployed are
